Catalyst Wire Dossier Catalyst Wire Dossier

Lupron (leuprolide)

leuprolide · AbbVie
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Lupron (leuprolide), covering 2025-07-30 to 2025-07-30. Get the full timeline:

Most recent: Clinical Trial Update: Combined Apalutamide, Radiotherapy, and LHRH Agonist in Prostate Cancer Patients After Prostatectomy [Phase 3]

See pricing